📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infections. (2021)

First Author: Walker AS

Attributed to: Method - Design funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(20)30791-x

PubMed Identifier: 33894130

Publication URI: http://europepmc.org/abstract/MED/33894130

Type: Journal Article/Review

Volume: 21

Parent Publication: The Lancet. Infectious diseases

Issue: 6

ISSN: 1473-3099